BG Medicine scuttles IPO - again

December 17, 2010 by MassDevice staff

BG Medicine Inc. withdraws its second initial public offering after failing to price the deal.

BG Medicine logo

BG Medicine Inc. scuttled its second initial public offering, having failed to set a price for the deal this week, nearly three years after it withdrew its first IPO.

The Waltham, Mass.-based diagnostics firm was expected to announce a price of between $13 and $15 per share this week for the 4.8 million share offering, but scrapped those plans, according to Dow Jones Newswires.

The most recent IPO was scaled back from plans BG announced in January for an $86.3 million offering. The company's shares were to have traded on the NASDAQ exchange under the BGMD symbol.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.